EEF2 and T-cell non-Hodgkin lymphoma: For example, diphtheria toxin, which ADP-ribosylates eEF2, conjugated to interleukin-2 (ONTAK) has been approved by the FDA for the treatment of T-cell lymphomas (62,63).